An Overview Of Biomedical Sciences

The biomedical filed is witnessing profound paradigm shift and the medical practice is moving toward a personalized type of healthcare based on scientific evidences and sophisticated technologies (1). However, and for multiple reasons this move is rather slow. Among these reasons is probably the current education medical system which is still focused on the quality of the clinical training and the integration of the latest biomedical sciences in the curriculum of healthcare professional is not optimal. Consequently, there is a concerning scarcity of individuals who are appropriately trained with skills that go across biomedical sciences and clinical practices, the latter being the essential links in the 21 century healthcare chain. Currently,

This is particularly true for institutions dedicated to train the next generation of life sciences and health biotechnology professionals. Indeed, the latest scientific developments have rendered the health biotechnology industry to be a sophisticated and increasingly powerful industry. This would not have happened without the necessary educational and research efforts led by the academic world. Therefore, a minted care should be taken in preparing the future generation of bio medical scientist if we want to stand a chance to meet the growing and high expectations for improved healthcare and quality of life, as the public is progressively aware of the potential applications of the latest developments in bio medical sciences and biotechnologies. A healthcare commensurate with the current knowledge and technical capabilities is an important issue all over today's globalized world. In addition, among the objectives of any new model that could be developed to prepare the next breed of professional bio medical scientists, is training students to understand how entrepreneurial skills can be applied in both the academic and the corporate

It consists in integrating the academic education into the links of the modern healthcare chain, namely the research and development, the clinical trials and regulatory affairs, the transfer of technology and the industrial production. This model should be delivered through a single institutional setting such as a school or institute dedicated to bio medical sciences. This is an incrementally innovative academic institutional concept based on tailoring the education to be not only based on research and development, but also to be tightly coupled to real-time industrial applications, all in one integrated geographical space. Such Institution will foster and advance the concept of learning by doing. It will realize the “from bench to bedside” or the “from molecule to man” paradigm. Consequently, the model requires a strong link with the pharmaceutical and medical industry. The involvement of these stakeholders is of paramount importance (6) as substantial part of the institution activities should be based on real medical and/or pharmaceutical projects. These projects can vary from product or service development to clinical trials or any kinds of advisory activities ranging from technical and scientific consultations to management, regulatory or legal supports. To put